Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?

Saved in:
Bibliographic Details
Published in:European journal of vascular and endovascular surgery 2023-08, Vol.66 (2), p.220-220
Main Authors: van de Water, Willemien, Siegerink, Bob
Format: Article
Language:English
Subjects:
Anticoagulants
Fibrinolytic Agents - adverse effects
Humans
Lower Extremity - blood supply
Peripheral Arterial Disease - diagnostic imaging
Peripheral Arterial Disease - drug therapy
Platelet Aggregation Inhibitors
Surgery
Vascular Diseases
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c362t-8512b4db6ee6da61f6dc1ac39d826c21051045b5369c262668576301d46bd1e83
container_end_page 220
container_issue 2
container_start_page 220
container_title European journal of vascular and endovascular surgery
container_volume 66
creator van de Water, Willemien
Siegerink, Bob
description
doi_str_mv 10.1016/j.ejvs.2023.05.012
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2815249867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078588423003738</els_id><sourcerecordid>2815249867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-8512b4db6ee6da61f6dc1ac39d826c21051045b5369c262668576301d46bd1e83</originalsourceid><addsrcrecordid>eNp9kU9v1DAUxCMEoqXwBTggH7kk9Z_YcSQEWnVLi7QVB1pxtBz7LXVI7K3tFPbbk2jbHjj09N5hZqT5TVG8J7gimIjTvoL-PlUUU1ZhXmFCXxTHhDNaUiL4y_nHjSy5lPVR8SalHmPMCeOviyPWkFa0hB8Xu5-3EAGtAyIVR1duGFzwaK2z3gXnc0Ib0BbdJOQ8upicdf4XWvns8m0MYxeyM-g6gs4j-IzCFm3CH4jo_G-OMLq8R6uYITo9oLVLoBN8eVu82uohwbuHe1LcfD2_PrssN98vvp2tNqVhguZSckK72nYCQFgtyFZYQ7RhrZVUGErmJrjmHWeiNVRQISRvBMPE1qKzBCQ7KT4ecncx3E2QshpdMjAM2kOYkqKScFq3UjSzlB6kJoaUImzVLrpRx70iWC2kVa8W0mohrTBXM-nZ9OEhf-pGsE-WR7Sz4NNBAHPLewdRJePAG7AugsnKBvd8_uf_7GZw3hk9_IY9pD5M0c_8FFGJKqx-LFsvU1OGMWuYZP8A422jMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2815249867</pqid></control><display><type>article</type><title>Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?</title><source>ScienceDirect Freedom Collection</source><creator>van de Water, Willemien ; Siegerink, Bob</creator><creatorcontrib>van de Water, Willemien ; Siegerink, Bob</creatorcontrib><identifier>ISSN: 1078-5884</identifier><identifier>EISSN: 1532-2165</identifier><identifier>DOI: 10.1016/j.ejvs.2023.05.012</identifier><identifier>PMID: 37196915</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Anticoagulants ; Fibrinolytic Agents - adverse effects ; Humans ; Lower Extremity - blood supply ; Peripheral Arterial Disease - diagnostic imaging ; Peripheral Arterial Disease - drug therapy ; Platelet Aggregation Inhibitors ; Surgery ; Vascular Diseases</subject><ispartof>European journal of vascular and endovascular surgery, 2023-08, Vol.66 (2), p.220-220</ispartof><rights>European Society for Vascular Surgery</rights><rights>2023 European Society for Vascular Surgery</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c362t-8512b4db6ee6da61f6dc1ac39d826c21051045b5369c262668576301d46bd1e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37196915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van de Water, Willemien</creatorcontrib><creatorcontrib>Siegerink, Bob</creatorcontrib><title>Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?</title><title>European journal of vascular and endovascular surgery</title><addtitle>Eur J Vasc Endovasc Surg</addtitle><subject>Anticoagulants</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Humans</subject><subject>Lower Extremity - blood supply</subject><subject>Peripheral Arterial Disease - diagnostic imaging</subject><subject>Peripheral Arterial Disease - drug therapy</subject><subject>Platelet Aggregation Inhibitors</subject><subject>Surgery</subject><subject>Vascular Diseases</subject><issn>1078-5884</issn><issn>1532-2165</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAUxCMEoqXwBTggH7kk9Z_YcSQEWnVLi7QVB1pxtBz7LXVI7K3tFPbbk2jbHjj09N5hZqT5TVG8J7gimIjTvoL-PlUUU1ZhXmFCXxTHhDNaUiL4y_nHjSy5lPVR8SalHmPMCeOviyPWkFa0hB8Xu5-3EAGtAyIVR1duGFzwaK2z3gXnc0Ib0BbdJOQ8upicdf4XWvns8m0MYxeyM-g6gs4j-IzCFm3CH4jo_G-OMLq8R6uYITo9oLVLoBN8eVu82uohwbuHe1LcfD2_PrssN98vvp2tNqVhguZSckK72nYCQFgtyFZYQ7RhrZVUGErmJrjmHWeiNVRQISRvBMPE1qKzBCQ7KT4ecncx3E2QshpdMjAM2kOYkqKScFq3UjSzlB6kJoaUImzVLrpRx70iWC2kVa8W0mohrTBXM-nZ9OEhf-pGsE-WR7Sz4NNBAHPLewdRJePAG7AugsnKBvd8_uf_7GZw3hk9_IY9pD5M0c_8FFGJKqx-LFsvU1OGMWuYZP8A422jMg</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>van de Water, Willemien</creator><creator>Siegerink, Bob</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230801</creationdate><title>Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?</title><author>van de Water, Willemien ; Siegerink, Bob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-8512b4db6ee6da61f6dc1ac39d826c21051045b5369c262668576301d46bd1e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anticoagulants</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Humans</topic><topic>Lower Extremity - blood supply</topic><topic>Peripheral Arterial Disease - diagnostic imaging</topic><topic>Peripheral Arterial Disease - drug therapy</topic><topic>Platelet Aggregation Inhibitors</topic><topic>Surgery</topic><topic>Vascular Diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van de Water, Willemien</creatorcontrib><creatorcontrib>Siegerink, Bob</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of vascular and endovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van de Water, Willemien</au><au>Siegerink, Bob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?</atitle><jtitle>European journal of vascular and endovascular surgery</jtitle><addtitle>Eur J Vasc Endovasc Surg</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>66</volume><issue>2</issue><spage>220</spage><epage>220</epage><pages>220-220</pages><issn>1078-5884</issn><eissn>1532-2165</eissn><cop>England</cop><pub>Elsevier B.V</pub><pmid>37196915</pmid><doi>10.1016/j.ejvs.2023.05.012</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-5884
ispartof European journal of vascular and endovascular surgery, 2023-08, Vol.66 (2), p.220-220
issn 1078-5884
1532-2165
language eng
recordid cdi_proquest_miscellaneous_2815249867
source ScienceDirect Freedom Collection
subjects Anticoagulants
Fibrinolytic Agents - adverse effects
Humans
Lower Extremity - blood supply
Peripheral Arterial Disease - diagnostic imaging
Peripheral Arterial Disease - drug therapy
Platelet Aggregation Inhibitors
Surgery
Vascular Diseases
title Where Do 1.5 Million Datapoints Lead Us in Guiding Antithrombotic Treatment of Lower Extremity Arterial Disease?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-27T07%3A11%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Where%20Do%201.5%20Million%20Datapoints%20Lead%20Us%20in%20Guiding%20Antithrombotic%20Treatment%20of%20Lower%20Extremity%20Arterial%20Disease?&rft.jtitle=European%20journal%20of%20vascular%20and%20endovascular%20surgery&rft.au=van%20de%20Water,%20Willemien&rft.date=2023-08-01&rft.volume=66&rft.issue=2&rft.spage=220&rft.epage=220&rft.pages=220-220&rft.issn=1078-5884&rft.eissn=1532-2165&rft_id=info:doi/10.1016/j.ejvs.2023.05.012&rft_dat=%3Cproquest_cross%3E2815249867%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-8512b4db6ee6da61f6dc1ac39d826c21051045b5369c262668576301d46bd1e83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2815249867&rft_id=info:pmid/37196915&rfr_iscdi=true